CD4 and HIV infectious disease: In addition to investigating the direct impact of LRAs on NK cells, we analyzed the impact of exposure to these agents on target cells relevant for HIV infection (resting CD4+ T cells) to assess expression of surface ligands that would render them more susceptible to NK cell recognition and clearance.